Arena Pharmaceuticals, Inc. (ARNA)

[ferretmoney]

I see you are well versed in sophomore debating skills. If you can't respond in substance attack the man.

You can not refute what I said and I couldn't care less what you think of me. The FDA's Colman committed a first-year med student error by combining malignant and benign tumors and then claiming there was cancer risk at all doses. WHAT? I don't know whether he's incompetent or corrupt, although my inclination is to think he fits the second description.

Then, if he was planning to bring up this misrepresented risk why was the panel stacked with unqualified people wrt that issue. It can not be accidental that the main thrust of Colman's attack fell on people who were not ready to evaluate its merit.